22.05.2017 Views

Review of Pharmacology - 9E (2015)

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Review</strong> <strong>of</strong> <strong>Pharmacology</strong><br />

isomerase and can convert cyclic endoperoxides to PGD 2<br />

, PGE 2<br />

and PGF 2α<br />

. Corticosteroids<br />

inhibit the enzyme phospholipase A 2<br />

by inducing the production <strong>of</strong> lipocortins (Now known as<br />

annexins). NSAIDs decrease PG and TX production by inhibiting COX.<br />

Actions<br />

Autacoids<br />

CNS<br />

PGE 1<br />

and PGE 2<br />

are pyrogenic and cause fever. NSAIDs act as antipyretic agents by inhibiting<br />

these PGs.<br />

Peripheral Nerve Endings<br />

PGE 2<br />

and PGI 2<br />

sensitize pain receptors to various mediators. NSAIDs act as analgesics by<br />

decreasing the synthesis <strong>of</strong> PGs.<br />

116<br />

Alprostadil is used to keep<br />

ductus arteriosus patent<br />

before surgery whereas NSAIDs<br />

like aspirin and indomethacin<br />

are used for treatment <strong>of</strong>. Patent<br />

ductus arteriosus<br />

CVS<br />

• PGE 2<br />

and PGI 2<br />

are vasodilators whereas PGF 2α<br />

and TXA 2<br />

are vasoconstrictor agents.<br />

Epoprostenol (PGI 2<br />

) and treprostinil (longer acting PGI 2<br />

analogue) can be used for the<br />

treatment <strong>of</strong> pulmonary hypertension.<br />

• PGE 2<br />

increases capillary permeability.<br />

• PGE 2<br />

and PGI 2<br />

keeps ductus arteriosus patent. In some congenital heart diseases (like<br />

transposition <strong>of</strong> great vessels), it becomes essential to keep ductus arteriosus patent<br />

before surgery. For this indication, alprostadil (PGE 1<br />

) and epoprostenol (PGI 2<br />

) can be<br />

given intravenously. If ductus arteriosus fails to close (patent ductus arteriosus) at<br />

birth, NSAIDs like aspirin and indomethacin are given to close it.<br />

Platelets<br />

• PGI 2<br />

inhibits platelet aggregation whereas TXA 2<br />

is a potent aggregator <strong>of</strong> platelets. Nonselective<br />

COX inhibitors inhibit the generation <strong>of</strong> both <strong>of</strong> these compounds. TXA 2<br />

is synthesized in platelets and its synthesis cannot be resumed, once it is inhibited<br />

by NSAIDs (because platelets lack nuclei) whereas synthesis <strong>of</strong> PGI 2<br />

resumes after<br />

sometime (endothelial cells can synthesize new COX). Net result <strong>of</strong> this process is<br />

inhibition <strong>of</strong> TXA 2<br />

synthesis and platelet anti-aggregation.<br />

• Low dose aspirin can be used as an antiplatelet drug for the prophylaxis <strong>of</strong> MI and<br />

stroke.<br />

• Epoprostenol (PGI 2<br />

) can be used as an anti-aggregatory drug in dialysis and cardiopulmo-<br />

https://kat.cr/user/Blink99/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!